JP2024522304A5 - - Google Patents
Info
- Publication number
- JP2024522304A5 JP2024522304A5 JP2024518956A JP2024518956A JP2024522304A5 JP 2024522304 A5 JP2024522304 A5 JP 2024522304A5 JP 2024518956 A JP2024518956 A JP 2024518956A JP 2024518956 A JP2024518956 A JP 2024518956A JP 2024522304 A5 JP2024522304 A5 JP 2024522304A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163196744P | 2021-06-04 | 2021-06-04 | |
| US63/196,744 | 2021-06-04 | ||
| PCT/US2022/032203 WO2022256680A1 (en) | 2021-06-04 | 2022-06-03 | Pyridopyrimidine derivatives useful as wee1 kinase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024522304A JP2024522304A (ja) | 2024-06-13 |
| JP2024522304A5 true JP2024522304A5 (https=) | 2025-06-10 |
| JPWO2022256680A5 JPWO2022256680A5 (https=) | 2025-06-10 |
Family
ID=82321319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024518956A Pending JP2024522304A (ja) | 2021-06-04 | 2022-06-03 | Ｗｅｅ１キナーゼ阻害剤として有用なピリドピリミジン誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240254123A1 (https=) |
| EP (1) | EP4347592A1 (https=) |
| JP (1) | JP2024522304A (https=) |
| KR (1) | KR20240044409A (https=) |
| CN (1) | CN117794932A (https=) |
| AU (2) | AU2022287033B2 (https=) |
| CA (1) | CA3225152A1 (https=) |
| IL (1) | IL309037A (https=) |
| MX (1) | MX2023014466A (https=) |
| WO (1) | WO2022256680A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL315441A (en) | 2022-03-07 | 2024-11-01 | Debiopharm Int Sa | Treatment methods for small cell lung cancer |
| IL326854A (en) | 2023-09-14 | 2026-04-01 | Debiopharm Int Sa | Combination of WEE1 inhibitor and PKMYT1 inhibitor |
| CN120189510A (zh) * | 2023-12-21 | 2025-06-24 | 北京哲源科技有限责任公司 | 一种并环化合物的应用 |
| TW202541810A (zh) | 2023-12-22 | 2025-11-01 | 瑞士商德彪製藥國際公司 | 治療實體腫瘤之方法 |
| WO2025186213A1 (en) | 2024-03-04 | 2025-09-12 | Debiopharm International S.A. | Combination of a wee1 inhibitor and a topoisomerase 1 inhibitor |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002098370A2 (en) | 2001-03-02 | 2002-12-12 | Medimmune, Inc. | Methods of administering/dosing cd2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disorders |
| AR060635A1 (es) * | 2006-04-27 | 2008-07-02 | Banyu Pharma Co Ltd | Derivados de 1,2-dihidro-3h-pirazolo[3,4-d]pirimidin-3-ona, composiciones farmaceuticas que los comprenden y su uso en el tratamiento del cancer |
| CN104271576A (zh) * | 2012-02-23 | 2015-01-07 | 艾伯维公司 | 激酶的吡啶并嘧啶酮抑制剂 |
| GB201306610D0 (en) * | 2013-04-11 | 2013-05-29 | Almac Discovery Ltd | Pharmaceutical compounds |
| GB201612095D0 (en) * | 2016-07-12 | 2016-08-24 | Almac Discovery Ltd | Pharmaceutical compounds |
| CA3071405A1 (en) * | 2017-08-01 | 2019-02-07 | Recurium Ip Holdings, Llc | 1, 2 - dihydro- 3h- pyrazolo [3, 4 - d] pyrimidin -3 - one analogs |
| GB201800378D0 (en) * | 2018-01-10 | 2018-02-21 | Almac Discovery Ltd | Pharmaceutical compounds |
-
2022
- 2022-06-03 AU AU2022287033A patent/AU2022287033B2/en active Active
- 2022-06-03 KR KR1020247000364A patent/KR20240044409A/ko active Pending
- 2022-06-03 MX MX2023014466A patent/MX2023014466A/es unknown
- 2022-06-03 US US18/565,598 patent/US20240254123A1/en active Pending
- 2022-06-03 WO PCT/US2022/032203 patent/WO2022256680A1/en not_active Ceased
- 2022-06-03 CA CA3225152A patent/CA3225152A1/en active Pending
- 2022-06-03 JP JP2024518956A patent/JP2024522304A/ja active Pending
- 2022-06-03 CN CN202280054331.6A patent/CN117794932A/zh active Pending
- 2022-06-03 EP EP22735735.7A patent/EP4347592A1/en active Pending
- 2022-06-03 IL IL309037A patent/IL309037A/en unknown
-
2025
- 2025-06-23 AU AU2025204724A patent/AU2025204724A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024522304A5 (https=) | ||
| JP2025509278A5 (https=) | ||
| CL2025003270A1 (es) | Composición antiparasitaria controlar infecciones parasitarias en colmenas | |
| BR102023007252A2 (https=) | ||
| BR102023005164A2 (https=) | ||
| BR102023001877A2 (https=) | ||
| BR202022005961U2 (https=) | ||
| BY13165U (https=) | ||
| CN307049034S (https=) | ||
| CN307045313S (https=) | ||
| CN307045267S (https=) | ||
| CN307045249S (https=) | ||
| CN307044981S (https=) | ||
| CN307047243S (https=) | ||
| BY24002C1 (https=) | ||
| BY23963C1 (https=) | ||
| BY13176U (https=) | ||
| BY13175U (https=) | ||
| BY13174U (https=) | ||
| BY13170U (https=) | ||
| BY13168U (https=) | ||
| BY13167U (https=) | ||
| BY13166U (https=) | ||
| BY13172U (https=) | ||
| CN307047284S (https=) |